29 related articles for article (PubMed ID: 20023900)
1. Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes.
Annunziata A; Amoresano A; Cucciolito ME; Esposito R; Ferraro G; Iacobucci I; Imbimbo P; Lucignano R; Melchiorre M; Monti M; Scognamiglio C; Tuzi A; Monti DM; Merlino A; Ruffo F
Inorg Chem; 2020 Mar; 59(6):4002-4014. PubMed ID: 32129608
[TBL] [Abstract][Full Text] [Related]
2. The influence of thioether-substituted ligands in dicopper(II) complexes: Enhancing oxidation and biological activities.
Durigon DC; Glitz VA; Pimenta BF; Guedes AMV; Silva JVO; Bella Cruz CC; Andrade LM; Pereira-Maia EC; Mikcha JMG; Bella Cruz A; Xavier FR; Terenzi HF; Poneti G; Ribeiro RR; Nordlander E; Caramori GF; Bortoluzzi AJ; Peralta RA
J Inorg Biochem; 2024 Jul; 256():112573. PubMed ID: 38678913
[TBL] [Abstract][Full Text] [Related]
3. Solution studies on DNA interactions of substitution-inert platinum complexes mediated via the phosphate clamp.
Qu Y; Kipping RG; Farrell NP
Dalton Trans; 2015 Feb; 44(8):3563-72. PubMed ID: 25524170
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
Lazić JM; Vucićević L; Grgurić-Sipka S; Janjetović K; Kaluderović GN; Misirkić M; Gruden-Pavlović M; Popadić D; Paschke R; Trajković V; Sabo TJ
ChemMedChem; 2010 Jun; 5(6):881-9. PubMed ID: 20408161
[TBL] [Abstract][Full Text] [Related]
5. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
[TBL] [Abstract][Full Text] [Related]
6. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
7. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
[TBL] [Abstract][Full Text] [Related]
8. Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.
Mihajlović LE; Savić A; Poljarević J; Vučković I; Mojić M; Bulatović M; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN; Stošić-Grujičić S; Miljković Đ; Grgurić-Šipka S; Sabo TJ
J Inorg Biochem; 2012 Apr; 109():40-8. PubMed ID: 22369771
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, in vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R = Et, n-Pr).
Kaluderović GN; Kommera H; Schwieger S; Paethanom A; Kunze M; Schmidt H; Paschke R; Steinborn D
Dalton Trans; 2009 Dec; (48):10720-6. PubMed ID: 20023900
[TBL] [Abstract][Full Text] [Related]
10. Chemistry and biological activity of platinum amidine complexes.
Michelin RA; Sgarbossa P; Sbovata SM; Gandin V; Marzano C; Bertani R
ChemMedChem; 2011 Jul; 6(7):1172-83. PubMed ID: 21630470
[TBL] [Abstract][Full Text] [Related]
11. Understanding trans platinum complexes as potential antitumor drugs beyond targeting DNA.
Quiroga AG
J Inorg Biochem; 2012 Sep; 114():106-12. PubMed ID: 22819649
[TBL] [Abstract][Full Text] [Related]
12. What do we know about the reduction of Pt(IV) pro-drugs?
Wexselblatt E; Gibson D
J Inorg Biochem; 2012 Dec; 117():220-9. PubMed ID: 22877926
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
